Shares of Aptevo Therapeutics (APVO) skyrocketed over 113% on a new Tang Capital disclosure.
- Aptevo Therapeutics rose 113% premarket, currently trading at $50.52 after Tang Capital Partners reported a 54.4% stake in a new 13D regulatory filing.
- The reporting persons have expended an aggregate of ~$28.1M to purchase 1.76M Aptevo shares through the open market.
- APVO share price has grown exponentially to ~267% over the past five days.
According to a recent filing, Tang Capital Partners has disclosed a 54% stake in the company, last week earlier shareholders saw a big surge in stock price after the document was published.
